FDC116115: A prospective study of sexual function in sexually active men treated for BPH
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Dutasteride/tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 23 Apr 2016 This trial is completed in Germany (end date: 5 Apr 2016), according to European Clinical Trials Database record.
- 21 Apr 2016 Status changed from recruiting to completed.
- 29 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.